Selected article for: "herpes virus and respiratory syncytial virus"

Author: Powers, Chelsea N.; Setzer, William N.
Title: An In-Silico Investigation of Phytochemicals as Antiviral Agents Against Dengue Fever
  • Document date: 2016_8_23
  • ID: q7thhtg3_25
    Snippet: Glycyrrhiza extracts have shown antiviral activity against human immunodeficiency virus [47, 48] , Newcastle disease virus [49] , human respiratory syncytial virus [50] and herpes simplex virus 1 [51] . Prenylated stilbenoids (3,3 ,4,5tetrahydroxy-5-prenylbibenzyl, 3,3 ,5 -trihydroxy-4methoxy-5-prenylbibenzyl, 3-acetoxy-4 ,5-dihydroxy-3prenyldihydrostilbene, licobenzofuran) and isoflavonoids (glycyrrhisoflavone, 4 -O-methylglycyrrhisoflavone) cha.....
    Document: Glycyrrhiza extracts have shown antiviral activity against human immunodeficiency virus [47, 48] , Newcastle disease virus [49] , human respiratory syncytial virus [50] and herpes simplex virus 1 [51] . Prenylated stilbenoids (3,3 ,4,5tetrahydroxy-5-prenylbibenzyl, 3,3 ,5 -trihydroxy-4methoxy-5-prenylbibenzyl, 3-acetoxy-4 ,5-dihydroxy-3prenyldihydrostilbene, licobenzofuran) and isoflavonoids (glycyrrhisoflavone, 4 -O-methylglycyrrhisoflavone) chalcones (kanzonol Y) from G. glabra have demonstrated outstanding docking properties to DENV protease (Table 1) . Prenylated phenolics from G. glabra have inhibited HIV giant cell formation [47] . In addition, kanzonol Y docked well with DENV RNA-dependent RNA polymerase and DENV envelope protein (see below). Glabraisoflavanone, also from G. glabra, docked well with DENV methyltransferase (see below).

    Search related documents:
    Co phrase search for related documents
    • antiviral activity and denv protease: 1, 2
    • antiviral activity and disease virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and envelope protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • antiviral activity and Glycyrrhiza extract: 1
    • antiviral activity and herpes simplex: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and herpes simplex virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and human immunodeficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and human immunodeficiency virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and human immunodeficiency virus antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • antiviral activity and human respiratory syncytial virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • antiviral activity and Newcastle disease virus: 1, 2, 3, 4, 5, 6, 7, 8
    • cell formation and giant cell formation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • cell formation and herpes simplex: 1, 2, 3, 4
    • cell formation and herpes simplex virus: 1, 2, 3, 4
    • cell formation and human immunodeficiency: 1, 2, 3, 4, 5, 6, 7
    • cell formation and human immunodeficiency virus: 1, 2, 3, 4, 5, 6, 7
    • cell formation and human immunodeficiency virus antiviral activity: 1
    • cell formation and human respiratory syncytial virus: 1, 2
    • cell formation and Newcastle disease virus: 1